BackXPhyto Therapeutics Overview

XPhyto Therapeutics Long Term Debt

Track XPhyto Therapeutics's long-term debt ($5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$4.96M
↓ 11.43% YoYΔ $-640531.00 vs prior year quarter

Peer trimmed avg / median

Loading

XPhyto Therapeutics Long Term Debt History

Loading

XPhyto Therapeutics vs. peers: Long Term Debt Comparison

Loading

XPhyto Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

XPhyto Therapeutics (4XT.DE) FAQ

As of the most recent data (September 2026), 4XT.DE shows a long-term debt of $5M. That compares with $5.6M in the prior-year period — down 11.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4XT.DE's long-term debt is now $5M (was $5.6M) — a 11.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether XPhyto Therapeutics is outperforming or lagging.

Tracking 4XT.DE's long-term debt over time shows whether XPhyto Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $5M That compares with $5.6M in the prior-year period — down 11.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has XPhyto Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $5M) with ownership activity and broader fundamentals.

Questions & Answers